Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

April 17, 2014 updated by: Zhang Manna, Shanghai 10th People's Hospital

The Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure in Patients With Obesity

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,lipid metabolism and blood pressure

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Effect of Meal Replacement Beverage(Glucerna) on Body Composition,lipid metabolism and blood pressure in Patients with Obesity

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 65 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age：14~60years
  2. BMI ≥ 28kg/m2
  3. without liver, kidney, gastrointestinal and other major organic serious diseases,lactating women, pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Glucerna,Meal Replacement
Glucerna 52g instead of night meal 5weeks
Dietary supplement: Glucerna
Glucerna 52g meal replacement
Other Names:
  • Glucerna （Abbort，SR）

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Dual energy X-ray absorptiometry
Time Frame: 5 weeks
5 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
lab testing
Time Frame: 5weeks
5weeks

Other Outcome Measures

Outcome Measure
Time Frame
blood pressure
Time Frame: 5 weeks
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shanghai 10th People's Hospital

Investigators

  • Study Director: Qu Shen, PhD, Shang Tenth People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (ACTUAL)

December 1, 2013

Study Completion (ACTUAL)

December 1, 2013

Study Registration Dates

First Submitted

April 1, 2014

First Submitted That Met QC Criteria

April 17, 2014

First Posted (ESTIMATE)

April 21, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

April 21, 2014

Last Update Submitted That Met QC Criteria

April 17, 2014

Last Verified

October 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Glucerna

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Glucerna

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe